These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30619369)

  • 1. Novel Role for PD-1:PD-L1 as Mediator of Pulmonary Vascular Endothelial Cell Functions in Pathogenesis of Indirect ARDS in Mice.
    Lomas-Neira J; Monaghan SF; Huang X; Fallon EA; Chung CS; Ayala A
    Front Immunol; 2018; 9():3030. PubMed ID: 30619369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BLOCKADE OF ENDOTHELIAL GROWTH FACTOR, ANGIOPOIETIN-2, REDUCES INDICES OF ARDS AND MORTALITY IN MICE RESULTING FROM THE DUAL-INSULTS OF HEMORRHAGIC SHOCK AND SEPSIS.
    Lomas-Neira JL; Heffernan DS; Ayala A; Monaghan SF
    Shock; 2016 Feb; 45(2):157-65. PubMed ID: 26529660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of endothelial, but not epithelial, cell expression of PD-L1 following severe shock attenuates the development of indirect acute lung injury in mice.
    Xu S; Yang Q; Bai J; Tao T; Tang L; Chen Y; Chung CS; Fallon EA; Ayala A
    Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L801-L812. PubMed ID: 31994912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed cell death receptor ligand 1 modulates the regulatory T cells' capacity to repress shock/sepsis-induced indirect acute lung injury by recruiting phosphatase SRC homology region 2 domain-containing phosphatase 1.
    Tang L; Bai J; Chung CS; Lomas-Neira J; Chen Y; Huang X; Ayala A
    Shock; 2015 Jan; 43(1):47-54. PubMed ID: 25057927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blockade of programmed death-ligand 1 attenuates indirect acute lung injury in mice through targeting endothelial cells but not epithelial cells].
    Sun B; Li X; Zheng G; Dong T; Li Y; Li H; Yan Y; Bai J; Xu S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jan; 31(1):37-43. PubMed ID: 30707867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and Pulmonary Injury After Neonatal Sepsis: PD1/PDL1's Contributions to Mouse and Human Immunopathology.
    Fallon EA; Chung CS; Heffernan DS; Chen Y; De Paepe ME; Ayala A
    Front Immunol; 2021; 12():634529. PubMed ID: 33746973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of indirect acute lung injury: a novel role for the coinhibitory receptor, programmed death-1.
    Monaghan SF; Thakkar RK; Heffernan DS; Huang X; Chung CS; Lomas-Neira J; Cioffi WG; Ayala A
    Ann Surg; 2012 Jan; 255(1):158-64. PubMed ID: 21997806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive glia promote development of CD103
    Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
    Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patho-Mechanisms for Hemorrhage/Sepsis-Induced Indirect Acute Respiratory Distress Syndrome: A Role for Lung TIE1 and Its Regulation by Neutrophils.
    Zhu J; Li J; Chung CS; Lomas-Neira JL; Ayala A
    Shock; 2022 Apr; 57(4):608-615. PubMed ID: 34907117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1/PD-L1 Provides Protective Role in Hypoxia-Induced Pulmonary Vascular Remodeling.
    Wang L; Mu M; Guo Y; Huang J; Zhang R; Zhang M; Hu Y; Wang Y; Gao Z; Liu L; Wang W; Cheng Y; Zhu X; Liu J; Wang W; Ying S
    Hypertension; 2024 Aug; 81(8):1822-1836. PubMed ID: 38853755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel role for programmed cell death receptor ligand 2 in sepsis-induced hepatic dysfunction.
    Rossi AL; Le M; Chung CS; Chen Y; Fallon EA; Matoso A; Xu S; Chun TT; Erickson CP; Ayala A
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G106-G114. PubMed ID: 30431333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-endothelial interactions mediate angiopoietin-2-associated pulmonary endothelial cell dysfunction in indirect acute lung injury in mice.
    Lomas-Neira J; Venet F; Chung CS; Thakkar R; Heffernan D; Ayala A
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):193-200. PubMed ID: 23980650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD-1/PD-L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis.
    Hu YM; Hsiung YC; Pai MH; Yeh SL
    JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):538-549. PubMed ID: 28633555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 Ameliorates Murine Acute Graft-Versus-Host Disease by Suppressing Effector But Not Regulatory T Cells Function.
    Tang L; Ma S; Gong H; Wang J; Xu Y; Wu D; Sun A
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):179-187. PubMed ID: 30927016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis.
    Huang X; Chen Y; Chung CS; Yuan Z; Monaghan SF; Wang F; Ayala A
    J Immunol; 2014 Feb; 192(3):1091-9. PubMed ID: 24379123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation.
    Li W; Tu J; Liu X; Yang W
    Clin Exp Immunol; 2017 Oct; 190(1):8-18. PubMed ID: 28556912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed death-1
    Singh A; Mohan A; Dey AB; Mitra DK
    Clin Exp Immunol; 2017 Feb; 187(2):269-283. PubMed ID: 27665733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling the role of PD-L1 in vascular endothelial dysfunction: Insights into the mtros/NLRP3/caspase-1 mediated pyroptotic pathway.
    Tao T; Zhu Y; Shi Y; Sun B; Gu Y; Xu S
    Exp Cell Res; 2024 May; 438(1):114047. PubMed ID: 38631546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.
    Tewalt EF; Cohen JN; Rouhani SJ; Guidi CJ; Qiao H; Fahl SP; Conaway MR; Bender TP; Tung KS; Vella AT; Adler AJ; Chen L; Engelhard VH
    Blood; 2012 Dec; 120(24):4772-82. PubMed ID: 22993390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1.
    Kythreotou A; Siddique A; Mauri FA; Bower M; Pinato DJ
    J Clin Pathol; 2018 Mar; 71(3):189-194. PubMed ID: 29097600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.